🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchCan we talk about how SLOW the FDA is — my results so far Page 9

Can we talk about how SLOW the FDA is — my results so far

NurseAsh_DET Tue, Nov 18, 2025 at 7:47 PM 43 replies 1,294 viewsPage 9 of 9
MeganSA_TX
Member
634
2,890
Jun 2024
San Antonio, TX
Apr 26, 2026 at 8:07 AM#41
DataDave said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. I will report back once I have actually tried it.

Last edited: Apr 26, 2026 at 10:07 AM
43 16PharmD_Rodriguez, julia.endo, JessicaM_2024 and 40 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
May 3, 2026 at 5:08 AM#42

From the other side of the consultation, briefly. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Ask again with the specifics and you will get a better answer than this one.

44 17Dr.GutHealth, amsterdam_pete, LondonLisa and 41 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
May 10, 2026 at 2:06 AM#43

Moderator note: the sourcing question belongs in the vendor section and has been split out. Tagging this one for the weekly digest.

Last edited: May 10, 2026 at 4:06 AM
45 18DoseLogDan, SleepFixSam, PurityPaulOR and 42 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
B12Beth
Member
289
890
Oct 2024
Maryland
May 16, 2026 at 11:00 PM#44
PharmacoVig_BOS said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Adding the part of the answer the thread has not reached. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

46 19marco_milano, pam_columbus, nick_SD_fit and 43 others
Reply Quote Save Share Report
DoseLogDan
Member
201
567
Feb 2025
Montana
May 23, 2026 at 7:49 PM#45

One concrete data point for the thread. One practical note: write down what you did and when, before you need it. Reconstructing a timeline from memory three months later is how people end up unable to answer the one question that would have resolved it.

Last edited: May 23, 2026 at 8:49 PM
47 20carlos_SATX, sophie_paris, mel_PDX and 44 others
Reply Quote Save Share Report
1789

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register